Difluoroethylamines as an amide isostere in inhibitors of cathepsin K

被引:19
|
作者
Isabel, Elise [1 ]
Mellon, Christophe [1 ]
Boyd, Michael J. [1 ]
Chauret, Nathalie [1 ]
Deschenes, Denis [1 ]
Desmarais, Sylvie [1 ]
Falgueyret, Jean-Pierre [1 ]
Gauthier, Jacques Yves [1 ]
Khougaz, Karine [1 ]
Lau, Cheuk K. [1 ]
Leger, Serge [1 ]
Levorse, Dorothy A. [3 ]
Li, Chun Sing [1 ]
Masse, Frederic [1 ]
Percival, M. David [1 ]
Roy, Bruno [1 ]
Scheigetz, John [1 ]
Therien, Michel [1 ]
Truong, Vouy Linh [1 ]
Wesolowski, Gregg [2 ]
Young, Robert N. [1 ]
Zamboni, Robert [1 ]
Black, W. Cameron [1 ]
机构
[1] Merck Frosst Ctr Therapeut Res, Quebec City, PQ H9H 3L1, Canada
[2] Merck Res Labs, Dept Bone Biol & Osteoporosis, West Point, PA 19486 USA
[3] Merck Res Labs, Dept Pharmaceut Analyt Chem, Rahway, NJ 07065 USA
关键词
Cathepsin K; Cat K; Difluoroethylamine; log D; pK(a); POTENT;
D O I
10.1016/j.bmcl.2010.12.070
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The trifluoroethylamine group found in cathepsin K inhibitors like odanacatib can be replaced by a difluoroethylamine group. This change increased the basicity of the nitrogen which positively impacted the log D. This translated into an improved oral bioavailability in pre-clinical species. Difluoroethylamine compounds exhibit a similar potency against cathepsin K and selectivity profile against other cathepsins when compared to trifluoroethylamine analogs. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:920 / 923
页数:4
相关论文
共 50 条
  • [31] Identification of potent and selective VEGFR receptor tyrosine kinase inhibitors having new amide isostere headgroups
    Gaudette, Frederic
    Raeppel, Stephane
    Nguyen, Hannah
    Beaulieu, Normand
    Beaulieu, Carole
    Dupont, Isabelle
    Macleod, A. Robert
    Besterman, Jeffrey M.
    Vaisburg, Arkadii
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 848 - 852
  • [32] Potent HIV protease inhibitors containing a novel (2-phenylsulfanyl-1-hydroxyethyl)amide isostere
    Rocheblave, L
    Priem, G
    De Michelis, C
    Kraus, JL
    TETRAHEDRON LETTERS, 1999, 40 (22) : 4173 - 4176
  • [33] Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?
    Adkison, KK
    Barrett, DG
    Deaton, DN
    Gampe, RT
    Hassell, AM
    Long, ST
    McFadyen, RB
    Miller, AB
    Miller, LR
    Payne, JA
    Shewchuk, LM
    Wells-Knecht, KJ
    Willard, DH
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (04) : 978 - 983
  • [34] Bone effects of cathepsin K inhibitors in the growing rabbit
    Pennypacker, B.
    Rodan, S.
    Rodan, G.
    Black, C.
    Oballa, R.
    Wehren, L. E.
    Kimmel, D.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S153 - S153
  • [35] In search of selective inhibitors of cysteine protease, cathepsin K
    Wieczerzak, E
    Drabik, P
    Abrahamson, M
    Grubb, A
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2005, 11 (03) : 203 - 209
  • [36] New cathepsin K inhibitors containing argininal thiosemicarbazones
    Yeramala, Durga
    Guda, Bharat
    Akula, Prashanth
    Tha, Soe
    Rahman, Franklin
    Kadasala, Naveen Reddy
    Malayala, Karthik
    Jin, Jin
    Zhang, Shaozhong
    Wen, Lisa
    Huang, Jenq-Kuen
    McConnell, Rose M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [37] Cathepsin K Inhibitors Isolated from Ginger Rhizome
    James Almada da Silva
    Caio Yu dos Santos
    Mohadese Mohammadi
    João Batista Fernandes
    Maria Fátima das Graças Fernandes da Silva
    Paulo Cezar Vieira
    Revista Brasileira de Farmacognosia, 2021, 31 : 859 - 864
  • [38] Bone effects of cathepsin K inhibitors in the growing rabbit
    Pennypacker, B.
    Rodan, S.
    Rodan, G.
    Black, C.
    Oballa, R.
    Wehren, Lois E.
    Kimmel, D.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S194 - S195
  • [39] Cathepsin K inhibitors: A novel target for osteoporosis therapy
    Stoch, S. A.
    Wagner, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) : 172 - 176
  • [40] Acyclic cyanamide-based inhibitors of cathepsin K
    Barrett, DG
    Deaton, DN
    Hassell, AM
    McFadyen, RB
    Miller, AB
    Miller, LR
    Payne, JA
    Shewchuk, LM
    Willard, DH
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (12) : 3039 - 3043